QIYE LI: Open Payments
NPI 1457820623 · WELLESLEY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$751 in 23 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $363 · 2025 $751
Food & beverage: $751
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $207 |
| Lilly USA, LLC | 6 | $132 |
| ABIOMED | 2 | $130 |
| AstraZeneca Pharmaceuticals LP | 4 | $95 |
| ABBVIE INC. | 2 | $42 |
| Insmed, Inc. | 2 | $34 |
| Hologic Sales and Service, LLC | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: JARDIANCE, MOUNJARO, AIRSUPRA, BREZTRI, QULIPTA, Arikayce, APTIMA, Wegovy.
Industry payments across MA — which companies pay providers there.
